These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32702023)

  • 21. Pertussis vaccination and whooping cough: and now what?
    Guiso N
    Expert Rev Vaccines; 2014 Oct; 13(10):1163-5. PubMed ID: 25020131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunity to pertussis. Not all virulence factors are protective antigens.
    Robbins JB; Schneerson R; Bryla DA; Trollfors B; Taranger J; Lagergård T
    Adv Exp Med Biol; 1998; 452():207-18. PubMed ID: 9889975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How Genomics Is Changing What We Know About the Evolution and Genome of Bordetella pertussis.
    Ring N; Abrahams JS; Bagby S; Preston A; MacArthur I
    Adv Exp Med Biol; 2019; 1183():1-17. PubMed ID: 31321755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Whooping cough].
    Bos SE
    Ned Tijdschr Geneeskd; 1984 Jul; 128(30):1409-11. PubMed ID: 6089007
    [No Abstract]   [Full Text] [Related]  

  • 25. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.
    Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK
    Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antigens of Bordetella pertussis and their repercussion in immunization programs against whooping cough].
    Casal Lombos J
    Rev Sanid Hig Publica (Madr); 1971 May; 45(5):575-87. PubMed ID: 4330706
    [No Abstract]   [Full Text] [Related]  

  • 27. Resurgence of pertussis calls for re-evaluation of pertussis animal models.
    van der Ark AA; Hozbor DF; Boog CJ; Metz B; van den Dobbelsteen GP; van Els CA
    Expert Rev Vaccines; 2012 Sep; 11(9):1121-37. PubMed ID: 23151168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.
    Hegerle N; Guiso N
    Expert Rev Vaccines; 2014 Sep; 13(9):1135-46. PubMed ID: 24953157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pertactin-negative variants of Bordetella pertussis in New York State: a retrospective analysis, 2004-2013.
    Quinlan T; Musser KA; Currenti SA; Zansky SM; Halse TA
    Mol Cell Probes; 2014 Aug; 28(4):138-40. PubMed ID: 24365130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How can we eradicate pertussis.
    Cherry JD
    Adv Exp Med Biol; 2009; 634():41-51. PubMed ID: 19280847
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety and effectiveness of an acellular pertussis vaccine in subjects with Down's syndrome.
    Li Volti S; Mattina T; Mauro L; Bianca S; Anfuso S; Ursino A; Mollica F
    Childs Nerv Syst; 1996 Feb; 12(2):100-2. PubMed ID: 8674075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding the true burden and infection dynamics of Bordetella pertussis using molecular diagnostics.
    Curran T; Coyle PV
    J Infect; 2016 Apr; 72(4):504-5. PubMed ID: 26826519
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical forum. 12. Whooping cough.
    Pinchen C
    Nurs Mirror; 1982 Dec; 155(23):24-31. PubMed ID: 6296799
    [No Abstract]   [Full Text] [Related]  

  • 34. The advent of recombinant pertussis vaccines.
    Burnette WN
    Biotechnology (N Y); 1990 Nov; 8(11):1002-5. PubMed ID: 1366927
    [No Abstract]   [Full Text] [Related]  

  • 35. Resurgence and atypical patterns of pertussis in China.
    Mengyang G; Yahong H; Qinghong M; Wei S; Kaihu Y
    J Infect; 2024 Apr; 88(4):106140. PubMed ID: 38513738
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of biological activities of Bordetella pertussis mutants lacking the ability to produce filamentous hemagglutinin with similar activities of other smooth strains.
    Watanabe M; Munoz JJ
    Microbiol Immunol; 1982; 26(10):965-9. PubMed ID: 6298581
    [No Abstract]   [Full Text] [Related]  

  • 37. Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017.
    Xu Z; Octavia S; Luu LDW; Payne M; Timms V; Tay CY; Keil AD; Sintchenko V; Guiso N; Lan R
    Emerg Infect Dis; 2019 Jun; 25(6):1196-1199. PubMed ID: 31107218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bordetella pertussis: why is it still circulating?
    Guiso N
    J Infect; 2014 Jan; 68 Suppl 1():S119-24. PubMed ID: 24103807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Keeping pace with the elusive Bordetella pertussis.
    Grant CC; Cherry JD
    J Infect; 2002 Jan; 44(1):7-12. PubMed ID: 11972411
    [No Abstract]   [Full Text] [Related]  

  • 40. From pertussis to meningococcal disease and back.
    Gorringe A
    Hum Vaccin; 2011 Apr; 7(4):398-401. PubMed ID: 21795847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.